Breaking News Instant updates and real-time market news.

DRNA

Acquired by NVO

$38.01 /

-0.165 (-0.43%)

19:12
12/08/21
12/08
19:12
12/08/21
19:12

Dicerna downgraded to Neutral from Buy at Chardan

Chardan analyst Keay Nakae downgraded Dicerna to Neutral from Buy with a price target of $38.25, up from $28.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Asure Software, Certegy partner for technology integration » 08:25
01/24/22
01/24
08:25
01/24/22
08:25
ASUR

Asure Software

$7.05 /

-0.055 (-0.77%)

Asure Software announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASUR Asure Software
$7.05 /

-0.055 (-0.77%)

ASUR Asure Software
$7.05 /

-0.055 (-0.77%)

11/09/21 Cowen
Asure Software assumed with an Outperform at Cowen
ASUR Asure Software
$7.05 /

-0.055 (-0.77%)

Conference/Events
Matinas BioPharma to host business news update conference call » 08:25
01/24/22
01/24
08:25
01/24/22
08:25
MTNB

Matinas BioPharma

/

+

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTNB Matinas BioPharma
/

+

MTNB Matinas BioPharma
/

+

09/13/21 Piper Sandler
Matinas' next steps for MAT2203 'still unclear,' says Piper Sandler
05/11/21 Piper Sandler
Matinas BioPharma downgraded to Neutral from Overweight at Piper Sandler
03/30/21 H.C. Wainwright
Matinas BioPharma price target lowered to $3 from $4 at H.C. Wainwright
02/01/21 Piper Sandler
Matinas trial shows 'robust' serum increass despite miss, says Piper Sandler
MTNB Matinas BioPharma
/

+

Conference/Events
Vaccitech to hold a virtual key opinion leader event » 08:25
01/24/22
01/24
08:25
01/24/22
08:25
VACC

Vaccitech

$9.31 /

-0.32 (-3.32%)

Virtual Key Opinion…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VACC Vaccitech
$9.31 /

-0.32 (-3.32%)

VACC Vaccitech
$9.31 /

-0.32 (-3.32%)

05/25/21 William Blair
Vaccitech initiated with an Outperform at William Blair
05/25/21 Morgan Stanley
Vaccitech initiated with an Overweight at Morgan Stanley
05/25/21 Jefferies
Vaccitech initiated with a Buy at Jefferies
05/24/21 H.C. Wainwright
Vaccitech initiated with a Buy at H.C. Wainwright
VACC Vaccitech
$9.31 /

-0.32 (-3.32%)

  • 30
    Apr
Earnings
Goosehead Insurance sees 2021 revenue $150M-$152M, consensus $152.83M » 08:23
01/24/22
01/24
08:23
01/24/22
08:23
GSHD

Goosehead Insurance

$92.58 /

+0.63 (+0.69%)

Total written premiums…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GSHD Goosehead Insurance
$92.58 /

+0.63 (+0.69%)

GSHD Goosehead Insurance
$92.58 /

+0.63 (+0.69%)

07:03 Today Piper Sandler
Goosehead Insurance price target lowered to $140 from $160 at Piper Sandler
01/14/22 JMP Securities
Goosehead Insurance price target lowered to $160 from $170 at JMP Securities
10/18/21
Fly Intel: Top five analyst downgrades
10/18/21 BofA
Goosehead Insurance downgraded to Underperform on valuation at BofA
GSHD Goosehead Insurance
$92.58 /

+0.63 (+0.69%)

Recommendations
Ashland price target lowered to $120 from $133 at BMO Capital » 08:23
01/24/22
01/24
08:23
01/24/22
08:23
ASH

Ashland

$96.64 /

-1.49 (-1.52%)

BMO Capital analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASH Ashland
$96.64 /

-1.49 (-1.52%)

ASH Ashland
$96.64 /

-1.49 (-1.52%)

01/19/22 Wells Fargo
Ashland downgraded to Equal Weight from Overweight at Wells Fargo
01/19/22 Wells Fargo
Ashland downgraded to Equal Weight from Overweight at Wells Fargo
01/19/22 Deutsche Bank
Ashland price target lowered to $125 from $128 at Deutsche Bank
01/18/22 Stifel
Stifel sees any weakness in Ashland shares as a buying opportunity
ASH Ashland
$96.64 /

-1.49 (-1.52%)

Earnings
Goosehead Insurance sees Q4 revenue $39M-$41M, consensus $41.76M » 08:22
01/24/22
01/24
08:22
01/24/22
08:22
GSHD

Goosehead Insurance

$92.58 /

+0.63 (+0.69%)

Total written premiums…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GSHD Goosehead Insurance
$92.58 /

+0.63 (+0.69%)

GSHD Goosehead Insurance
$92.58 /

+0.63 (+0.69%)

07:03 Today Piper Sandler
Goosehead Insurance price target lowered to $140 from $160 at Piper Sandler
01/14/22 JMP Securities
Goosehead Insurance price target lowered to $160 from $170 at JMP Securities
10/18/21
Fly Intel: Top five analyst downgrades
10/18/21 BofA
Goosehead Insurance downgraded to Underperform on valuation at BofA
GSHD Goosehead Insurance
$92.58 /

+0.63 (+0.69%)

Hot Stocks
Save Foods partners with Galilee Export on bell pepers » 08:21
01/24/22
01/24
08:21
01/24/22
08:21
SVFD

Save Foods

$5.19 /

+1.12 (+27.52%)

SAVE FOODS announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SVFD Save Foods
$5.19 /

+1.12 (+27.52%)

  • 14
    May
Earnings
Trinseo sees Q4 Adj. EBITDA $129M-$135M  08:21
01/24/22
01/24
08:21
01/24/22
08:21
TSE

Trinseo

$54.00 /

-2.07 (-3.69%)

 
ShowHide Related Items >><<
TSE Trinseo
$54.00 /

-2.07 (-3.69%)

TSE Trinseo
$54.00 /

-2.07 (-3.69%)

08/06/21 Citi
Trinseo price target lowered to $57 from $64 at Citi
07/21/21 Tudor Pickering
Trinseo upgraded to Buy from Hold at Tudor Pickering
05/26/21 Morgan Stanley
Trinseo resumed with an Equal Weight at Morgan Stanley
05/11/21 Citi
Trinseo price target raised to $70 from $66 at Citi
TSE Trinseo
$54.00 /

-2.07 (-3.69%)

TSE Trinseo
$54.00 /

-2.07 (-3.69%)

Hot Stocks
Franklin Electric raises quarterly dividend 11% to 19.5c per share » 08:20
01/24/22
01/24
08:20
01/24/22
08:20
FELE

Franklin Electric

$86.65 /

-0.24 (-0.28%)

Franklin Electric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FELE Franklin Electric
$86.65 /

-0.24 (-0.28%)

FELE Franklin Electric
$86.65 /

-0.24 (-0.28%)

03/22/21 DA Davidson
Franklin Electric price target raised to $75 from $70 at DA Davidson
FELE Franklin Electric
$86.65 /

-0.24 (-0.28%)

Hot Stocks
Chinook appoints Jones-Burton as SVP of product development, strategy » 08:19
01/24/22
01/24
08:19
01/24/22
08:19
KDNY

Chinook Therapeutics

$12.76 /

-0.32 (-2.45%)

Chinook Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KDNY Chinook Therapeutics
$12.76 /

-0.32 (-2.45%)

KDNY Chinook Therapeutics
$12.76 /

-0.32 (-2.45%)

04/05/21 H.C. Wainwright
Chinook spinoff 'prudent way' to maximize Aduro value, says H.C. Wainwright
03/30/21 Cantor Fitzgerald
Cantor says Chinook BION-1301 abstract suggests positive proof of concept
KDNY Chinook Therapeutics
$12.76 /

-0.32 (-2.45%)

  • 10
    Nov
Hot Stocks
Endra revives IRB approval from Shanghai General Hospital for TAEUS study » 08:18
01/24/22
01/24
08:18
01/24/22
08:18
NDRA

Endra Life Sciences

/

+

Endra Life Sciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NDRA Endra Life Sciences
/

+

Hot Stocks
Aequus, Sandoz Canada agree to extension on Tacrolimus IR agreement » 08:18
01/24/22
01/24
08:18
01/24/22
08:18
NVS

Novartis

$87.01 /

-1.18 (-1.34%)

Aequus Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVS Novartis
$87.01 /

-1.18 (-1.34%)

NVS Novartis
$87.01 /

-1.18 (-1.34%)

01/12/22 Alliance Global Partners
OpGen price target lowered to $3 from $4.35 at Alliance Global Partners
01/10/22 Citi
Novartis resumed with a Buy at Citi
01/06/22 Piper Sandler
Piper want to own Alnylam shares ahead of expected vutrisiran approval
12/15/21 Berenberg
Novartis price target lowered to CHF 85 from CHF 88 at Berenberg
NVS Novartis
$87.01 /

-1.18 (-1.34%)

NVS Novartis
$87.01 /

-1.18 (-1.34%)

NVS Novartis
$87.01 /

-1.18 (-1.34%)

NVS Novartis
$87.01 /

-1.18 (-1.34%)

Hot Stocks
Avita Medical's RECELL system to be presented at burn, wound care symposium » 08:17
01/24/22
01/24
08:17
01/24/22
08:17
RCEL

Avita Medical

$9.60 /

-0.29 (-2.93%)

AVITA Medical announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCEL Avita Medical
$9.60 /

-0.29 (-2.93%)

RCEL Avita Medical
$9.60 /

-0.29 (-2.93%)

08/27/21 Piper Sandler
Investors should build positions in Avita Medical, says Piper Sandler
06/16/21 Piper Sandler
Avita Medical Q4 results show demand is growing, says Piper Sandler
03/02/21
Fly Intel: Top five analyst initiations
03/02/21 Piper Sandler
Avita Medical initiated with an Overweight at Piper Sandler
RCEL Avita Medical
$9.60 /

-0.29 (-2.93%)

  • 25
    Feb
Hot Stocks
Arcturus Therapeutics updates data from ARCT-154 , ARCT-165 booster trial » 08:17
01/24/22
01/24
08:17
01/24/22
08:17
ARCT

Arcturus Therapeutics

$24.60 /

-0.78 (-3.07%)

Arcturus Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARCT Arcturus Therapeutics
$24.60 /

-0.78 (-3.07%)

ARCT Arcturus Therapeutics
$24.60 /

-0.78 (-3.07%)

12/16/21 Piper Sandler
Arcturus data shows 'legit player' in COVID vaccines, says Piper Sandler
12/09/21 Piper Sandler
December kicks off catalyst rich month for Arcturus Therapeutics, says Piper
11/16/21 Cantor Fitzgerald
Arcturus Therapeutics price target raised to $93 from $85 at Cantor Fitzgerald
11/09/21 Barclays
Arcturus Therapeutics price target lowered to $31 from $46 at Barclays
ARCT Arcturus Therapeutics
$24.60 /

-0.78 (-3.07%)

ARCT Arcturus Therapeutics
$24.60 /

-0.78 (-3.07%)

Hot Stocks
Lionheart Acquisition urges stockholders to vote for extension amendment » 08:16
01/24/22
01/24
08:16
01/24/22
08:16
LCAP

Lionheart Acquisition Corporation II

$9.99 /

+0.01 (+0.10%)

Lionheart Acquisition…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LCAP Lionheart Acquisition Corporation II
$9.99 /

+0.01 (+0.10%)

Hot Stocks
Reservoir Media acquires publishing, recorded music catalogs of Travis Tritt » 08:16
01/24/22
01/24
08:16
01/24/22
08:16
RSVR

Reservoir Media

$6.86 /

-0.08 (-1.15%)

Reservoir Media announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RSVR Reservoir Media
$6.86 /

-0.08 (-1.15%)

RSVR Reservoir Media
$6.86 /

-0.08 (-1.15%)

08/23/21 Craig-Hallum
Craig-Hallum bullish on Reservoir Media, initiates with a Buy
08/23/21 Craig-Hallum
Reservoir Media initiated with a Buy at Craig-Hallum
08/23/21 Roth Capital
Reservoir Media initiated with a Buy at Roth Capital
RSVR Reservoir Media
$6.86 /

-0.08 (-1.15%)

Recommendations
IHS Markit price target lowered to $118 from $142 at BMO Capital » 08:15
01/24/22
01/24
08:15
01/24/22
08:15
INFO

IHS Markit

$117.59 /

-0.31 (-0.26%)

, SPGI

S&P Global

$416.89 /

-1.35 (-0.32%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INFO IHS Markit
$117.59 /

-0.31 (-0.26%)

SPGI S&P Global
$416.89 /

-1.35 (-0.32%)

INFO IHS Markit
$117.59 /

-0.31 (-0.26%)

12/28/21 Baird
S&P Global divestitures done satisfy merger regulatory conditions, says Baird
09/16/21 Oppenheimer
S&P Global price target raised to $550 from $476 at Oppenheimer
07/15/21 Deutsche Bank
IHS Markit price target raised to $127 from $123 at Deutsche Bank
07/15/21 Deutsche Bank
S&P Global price target raised to $450 from $435 at Deutsche Bank
SPGI S&P Global
$416.89 /

-1.35 (-0.32%)

01/14/22 BMO Capital
S&P Global price target raised to $511 from $509 at BMO Capital
12/28/21 Baird
S&P Global divestitures done satisfy merger regulatory conditions, says Baird
12/22/21 Oppenheimer
Coinbase, Nasdaq named Top Picks at Oppenheimer
09/16/21 Oppenheimer
S&P Global price target raised to $550 from $476 at Oppenheimer
INFO IHS Markit
$117.59 /

-0.31 (-0.26%)

SPGI S&P Global
$416.89 /

-1.35 (-0.32%)

  • 29
    Jun
  • 11
    May
INFO IHS Markit
$117.59 /

-0.31 (-0.26%)

SPGI S&P Global
$416.89 /

-1.35 (-0.32%)

INFO IHS Markit
$117.59 /

-0.31 (-0.26%)

SPGI S&P Global
$416.89 /

-1.35 (-0.32%)

Hot Stocks
AIM announces results from Phase 1/2 study of of IP chemo-immunotherapy » 08:14
01/24/22
01/24
08:14
01/24/22
08:14
AIM

AIM ImmunoTech

/

+

AIM ImmunoTech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AIM AIM ImmunoTech
/

+

AIM AIM ImmunoTech
/

+

Hot Stocks
Ortho Clinical Diagnostics schedules hearing with UK Court » 08:14
01/24/22
01/24
08:14
01/24/22
08:14
OCDX

Ortho Clinical Diagnostics

$17.97 /

-0.4 (-2.18%)

, QDEL

Quidel

$105.04 /

-4.54 (-4.14%)

Further to the joint…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCDX Ortho Clinical Diagnostics
$17.97 /

-0.4 (-2.18%)

QDEL Quidel
$105.04 /

-4.54 (-4.14%)

OCDX Ortho Clinical Diagnostics
$17.97 /

-0.4 (-2.18%)

12/27/21 Raymond James
Quidel acquisition brings 'lower ceiling on growth,' says Raymond James
12/27/21 H.C. Wainwright
Ortho Clinical downgraded to Neutral from Buy at H.C. Wainwright
12/27/21 Barclays
Ortho Clinical downgraded to Equal Weight from Overweight at Barclays
12/23/21 Evercore ISI
Evercore downgrades Ortho Clinical to In Line, doesn't see risk to deal closing
QDEL Quidel
$105.04 /

-4.54 (-4.14%)

12/27/21 Raymond James
Quidel acquisition brings 'lower ceiling on growth,' says Raymond James
12/27/21 H.C. Wainwright
Ortho Clinical downgraded to Neutral from Buy at H.C. Wainwright
12/23/21 Evercore ISI
Evercore downgrades Ortho Clinical to In Line, doesn't see risk to deal closing
12/23/21
Fly Intel: Top five analyst downgrades
OCDX Ortho Clinical Diagnostics
$17.97 /

-0.4 (-2.18%)

QDEL Quidel
$105.04 /

-4.54 (-4.14%)

  • 10
    Sep
  • 28
    Jan
QDEL Quidel
$105.04 /

-4.54 (-4.14%)

OCDX Ortho Clinical Diagnostics
$17.97 /

-0.4 (-2.18%)

QDEL Quidel
$105.04 /

-4.54 (-4.14%)

Hot Stocks
Nordstrom jumps 7% in premarket trading as Kohl's fields takeover interest  08:13
01/24/22
01/24
08:13
01/24/22
08:13
JWN

Nordstrom

$20.00 /

-0.89 (-4.26%)

, KSS

Kohl's

$46.83 /

-1.24 (-2.58%)

 
ShowHide Related Items >><<
JWN Nordstrom
$20.00 /

-0.89 (-4.26%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

JWN Nordstrom
$20.00 /

-0.89 (-4.26%)

12/03/21 Argus
Nordstrom supply chain remains strained, says Argus
11/29/21 Deutsche Bank
Nordstrom price target lowered to $27 from $37 at Deutsche Bank
11/26/21 Morgan Stanley
Morgan Stanley struggles to see viable path to Nordstrom EBIT target after Q3
11/24/21
Fly Intel: Top five analyst downgrades
KSS Kohl's
$46.83 /

-1.24 (-2.58%)

06:54 Today Credit Suisse
Kohl's take-out offer has some merit, says Credit Suisse
06:16 Today Citi
Kohl's 'mispriced,' so reasonable to consider offers, says Citi
01/07/22 UBS
Kohl's downgraded to Sell from Neutral at UBS
01/04/22 JPMorgan
Kohl's price target lowered to $55 from $73 at JPMorgan
JWN Nordstrom
$20.00 /

-0.89 (-4.26%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

JWN Nordstrom
$20.00 /

-0.89 (-4.26%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

JWN Nordstrom
$20.00 /

-0.89 (-4.26%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

JWN Nordstrom
$20.00 /

-0.89 (-4.26%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

Hot Stocks
Horizon Therapeutics enrolls first patient in HZN-825 trial » 08:13
01/24/22
01/24
08:13
01/24/22
08:13
HZNP

Horizon Therapeutics

$86.53 /

-0.18 (-0.21%)

Horizon Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HZNP Horizon Therapeutics
$86.53 /

-0.18 (-0.21%)

HZNP Horizon Therapeutics
$86.53 /

-0.18 (-0.21%)

01/18/22 JPMorgan
Horizon Therapeutics valuation 'compelling' after selloff, says JPMorgan
12/08/21
Fly Intel: Top five analyst initiations
12/08/21 Wells Fargo
Horizon Therapeutics initiated with an Overweight at Wells Fargo
11/18/21 Goldman Sachs
Horizon Therapeutics upgraded to Buy from Neutral at Goldman Sachs
HZNP Horizon Therapeutics
$86.53 /

-0.18 (-0.21%)

HZNP Horizon Therapeutics
$86.53 /

-0.18 (-0.21%)

HZNP Horizon Therapeutics
$86.53 /

-0.18 (-0.21%)

Hot Stocks
Macy's jumps over 8% in premarket trading as Kohl's fields takeover interest  08:13
01/24/22
01/24
08:13
01/24/22
08:13
M

Macy's

$22.93 /

-0.9 (-3.78%)

, KSS

Kohl's

$46.83 /

-1.24 (-2.58%)

 
ShowHide Related Items >><<
M Macy's
$22.93 /

-0.9 (-3.78%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

M Macy's
$22.93 /

-0.9 (-3.78%)

01/07/22 Evercore ISI
Evercore shifts portfolio to 'value oriented' retail names for 2022
01/04/22 JPMorgan
Macy's price target lowered to $33 from $37 at JPMorgan
12/10/21 Cowen
Macy's digital platform and valuation make it best idea for 2022, says Cowen
11/19/21 Credit Suisse
Macy's price target raised to $32 from $19 at Credit Suisse
KSS Kohl's
$46.83 /

-1.24 (-2.58%)

06:54 Today Credit Suisse
Kohl's take-out offer has some merit, says Credit Suisse
06:16 Today Citi
Kohl's 'mispriced,' so reasonable to consider offers, says Citi
01/07/22 UBS
Kohl's downgraded to Sell from Neutral at UBS
01/04/22 JPMorgan
Kohl's price target lowered to $55 from $73 at JPMorgan
M Macy's
$22.93 /

-0.9 (-3.78%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

M Macy's
$22.93 /

-0.9 (-3.78%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

M Macy's
$22.93 /

-0.9 (-3.78%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

M Macy's
$22.93 /

-0.9 (-3.78%)

KSS Kohl's
$46.83 /

-1.24 (-2.58%)

Downgrade
Barrington downgrades Opko Health on somatrogon regulatory setback » 08:11
01/24/22
01/24
08:11
01/24/22
08:11
OPK

Opko Health

$4.24 /

-0.12 (-2.75%)

, PFE

Pfizer

$52.78 /

-1.3 (-2.40%)

Barrington analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OPK Opko Health
$4.24 /

-0.12 (-2.75%)

PFE Pfizer
$52.78 /

-1.3 (-2.40%)

OPK Opko Health
$4.24 /

-0.12 (-2.75%)

08:03 Today Barrington
Opko Health downgraded to Market Perform from Outperform at Barrington
01/20/22 Piper Sandler
Piper reiterates $6 target on Opko after Japan approval, awaits FDA
01/18/22 Piper Sandler
Opko Health price target raised to $6 from $5 at Piper Sandler
09/27/21 Barrington
Barrington says Somatrogon delay does not change Opko Health view
PFE Pfizer
$52.78 /

-1.3 (-2.40%)

01/14/22 BMO Capital
Pfizer price target raised to $76 from $60 at BMO Capital
01/11/22 BofA
Pfizer added to US 1 List; Goldman Sachs removed at BofA
01/10/22 Wedbush
Beam Therapeutics price target raised to $159 from $148 at Wedbush
01/05/22 BofA
Pfizer upgraded to Buy from Neutral at BofA
OPK Opko Health
$4.24 /

-0.12 (-2.75%)

PFE Pfizer
$52.78 /

-1.3 (-2.40%)

PFE Pfizer
$52.78 /

-1.3 (-2.40%)

OPK Opko Health
$4.24 /

-0.12 (-2.75%)

PFE Pfizer
$52.78 /

-1.3 (-2.40%)

PFE Pfizer
$52.78 /

-1.3 (-2.40%)

Hot Stocks
Revelation Biosciences raises $7.76M in equity financing » 08:11
01/24/22
01/24
08:11
01/24/22
08:11
REVB

Revelation Biosciences

$3.27 /

-0.28 (-7.89%)

Revelation Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REVB Revelation Biosciences
$3.27 /

-0.28 (-7.89%)

Recommendations
PPG price target lowered to $181 from $199 at BMO Capital » 08:11
01/24/22
01/24
08:11
01/24/22
08:11
PPG

PPG

$154.75 /

-5.02 (-3.14%)

BMO Capital analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPG PPG
$154.75 /

-5.02 (-3.14%)

PPG PPG
$154.75 /

-5.02 (-3.14%)

07:11 Today Deutsche Bank
PPG price target lowered to $180 from $185 at Deutsche Bank
07:09 Today Wells Fargo
Wells Fargo downgrades PPG to Equal Weight, cuts price target to $170
06:43 Today Mizuho
PPG price target lowered to $182 from $187 at Mizuho
04:46 Today Wells Fargo
PPG downgraded to Equal Weight from Overweight at Wells Fargo
PPG PPG
$154.75 /

-5.02 (-3.14%)

PPG PPG
$154.75 /

-5.02 (-3.14%)

PPG PPG
$154.75 /

-5.02 (-3.14%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.